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Abstract 
Background: Albuminuria has been reported to be a marker of cardiovascular risk factors and 
disease morbidity and mortality, but the relationship with intracerebral atherosclerotic disease is 
less clear. 
Objectives: To identify determinants associated with increasing albuminuria in Chinese Type 2 
diabetic patients. 
Methods: Anthropometric and fasting biochemical parameters were compared between 857 Type 2 
diabetic patients with normo- (n=475), micro- (n=250) and macroalbuminuria (n=132) who were 
matched for age, gender, duration and age of onset of diabetes.  The prevalence of concomitant 
micro- and macrovascular disease and middle cerebral artery (MCA) stenoses, measured by 
transcranial Doppler, were also compared between the groups.   
Results: Albuminuria was closely associated with a range of adverse parameters, including high 
blood pressure, dyslipidaemia and adiposity (all p<0.001).  The prevalence of the micro- 
(retinopathy, p<0.001) and macrovascular diseases (peripheral vascular disease, p=0.012, 
myocardial infarction, p=0.010, MCA stenosis, p<0.001) increased significantly with increasing 
levels of albuminuria.  Albuminuria was also found to be an independent predictor of micro- and 
macrovascular diseases. 
Conclusions: Albuminuria was closely related to increasing levels of cardiovascular risk factors 
and micro- and macrovascular disease in this group of Type 2 diabetic patients and should be 
considered as a marker of early vascular disease.   
 
Keywords: blood pressure, retinopathy, peripheral vascular disease, cardiovascular disease, middle 
cerebral artery stenosis, metabolic syndrome 
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Introduction 
Cardiovascular disease is the major cause of morbidity and mortality in many developed and 
developing countries, including Hong Kong. In Oriental populations, there is a higher prevalence of 
stroke than in Caucasian populations where coronary heart disease (CHD) generally predominates.1,2 
Furthermore, despite increasing cholesterol levels in Asian countries, CHD mortality rates remain 3-5 
times lower than in most Western countries.  For instance, in the early 1990s in China age-adjusted 
mortality rates of 56 and 129/100,000 for CHD and stroke have been reported which contrast with those 
from US/UK Caucasians of 124/284 and 28/51 per 100,000, respectively.3  In addition to differences in 
prevalence rates, the distribution of arterial atherosclerotic lesions differs between Oriental and 
Caucasian populations.4,5  Similarly, intracerebral haemorrhage has been reported to be 2-3 times more 
frequent in Chinese than in Caucasian populations, accounting for 20-30% of strokes.5  
Even in Chinese populations, there is variability in CHD and stroke rates, which are higher in 
urban than in rural populations, and stroke rates are higher in the North of China, due to the high 
prevalence rates of hypertension.6  These intra-ethnic differences highlight the importance of 
environmental and lifestyle factors in the pathogenesis of these conditions.  Migration studies also 
support that changes in environmental challenges can have profound effects on the prevalence of 
vascular disease risk factors.7,8   
Ethnic differences associated with cardiovascular disease are therefore likely to result from the 
interaction of external environmental factors on the different genetic backgrounds.  Understanding the 
relative contribution of risk factors in different ethnic groups will help to clarify potential mechanisms 
involved in the pathogenesis of cardiovascular disease. 
In Chinese Type 2 diabetic patients, the prevalence of certain conditions such as 
hypertension and nephropathy are more common than in Caucasian diabetic populations.9,10 In 
Chinese diabetic patients, a random spot urine albumin-to-creatinine ratio (ACR) >5.6 mg/mmol 
predicts progression to renal failure and early death.11  Furthermore, the albuminuria associated 
with renal deterioration has been reported to be an index of atherosclerotic vascular disease 
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morbidity and mortality.12,13 However, our understanding of the relationship between albuminuria 
and intracranial atherosclerotic disease is less clear.  
In the current study, we report on the association between albuminuria, as determined using 
24 hour urinary albumin excretion rate, cardiovascular risk factors and the presence of intra- and 
extracranial cardiovascular disease in Chinese patients with Type 2 diabetes. 
 
Methods  
The study protocol was approved by the Clinical Research Ethics Committee of the Chinese 
University of Hong Kong.  All the Type 2 diabetic patients (n=966), recruited from the diabetes and 
neurology clinics at the Prince of Wales Hospital, were unrelated and gave written, informed 
consent.  They were of Han Chinese origin, without any known ancestors of other ethnic origin, and 
were living in the Hong Kong Special Administrative Region of China at the time of the study.  
Patients were considered diabetic if the fasting plasma glucose was ≥7.8 mmol/L or the two hour 
post 75g oral glucose tolerance test plasma glucose level was ≥11.1 mmol/L.14  Type 1 diabetic 
patients were defined on the basis of acute symptoms with heavy ketonuria (>3+) or ketoacidosis at 
diagnosis or requirement for continuous insulin treatment within one year of diagnosis and were 
excluded from the study.14  None of the type 2 diabetic patients screened had previously suffered 
from a stroke. 
Measurement of seated blood pressure, anthropometric (waist circumference and body mass 
index) and plasma biochemical (lipid and glycaemic profiles) parameters taken after an overnight 
fast have been described in detail previously.10,15  The patients’ medications were suspended for the 
morning of the examination providing assessment of trough levels, therefore assessment of the 
haemodynamic parameters as continuous variables is not possible.  Subjects were defined as 
hypertensive, if, after 5 minutes rest, their seated systolic blood pressure (SBP) was ≥140 mm Hg 
and/or diastolic blood pressure (DBP) ≥90 mm Hg on at least two occasions or they were receiving 
blood pressure-lowering medication.  Patients were assessed to rule out secondary causes of 
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hypertension and renal disease. Urine was collected over 24 hours and the albumin excretion rate 
(AER) and albumin-to-creatinine ratio (ACR) determined.  Urinary albumin concentration was 
measured by immunoturbidimetry.16  The lowest detection limit was 2.5 mg/L and inter- and intra-
assay CVs are less than 5%.  A midstream urine was collected for culture and microscopy results 
used to rule out infection.  Normoalbuminuria was classified as an AER <20 µg/min, 
microalbuminuria as an AER ≥20 to <200 µg/min and macroalbuminuria as an AER ≥200 µg/min.13 
In addition, we used an albumin-to-creatinine ratio >5.6 mg/mmol as a cut-off value as a predictor 
of end-stage renal disease.11  The albuminuric status of the 966 patients with Type 2 diabetes was 
determined from a 24 hour urine collection, from whom 857 patients matched for age, gender, 
duration and age of onset of diabetes were identified and included 475 patients with normo-, 250 
with micro-, and 132 with macroalbuminuria. 
The patients were examined by transcranial Doppler (EME TC-2000).  A single operator 
performed all the transcranial Doppler evaluations.  We studied the middle cerebral artery (MCA) 
using a standardised protocol examining the artery with 4cm increments through the temporal 
window at 52-64 mm; anterior cerebral artery (temporal window, 68-72 mm), posterior cerebral 
artery (temporal window, 56-64 mm), siphon internal carotid artery (orbital window, 60-68 mm), 
and vertebrobasilar artery (occipital window, 56-106 mm).17 Due to technical difficulty 
differentiating vascular lesions in the terminal internal carotid artery just before the bifurcation by 
transcranial Doppler we categorised the lesions as in the MCA.  The criteria for occlusive arteries 
were defined by the peak systolic flow velocity as follows: ≥140 cm/s for the MCA.17  Apart from 
the above velocity criteria, we took into account the age of patients, presence of turbulence or 
musical sound, and whether the abnormal velocity was segmental.  Where it was not possible for 
insonation of the cerebral arteries through the temporal window, the patients (13.3% of the total 
group) were excluded from the analyses.  The above diagnostic criteria in our neurovascular 
laboratory were based on our laboratory references, which had a quality assurance program with 
supplementary angiographic studies. [Gao S, Lam WWM, Chan YL, Liu JY, Wong KS. The 
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optimal values of flow velocity on transcranial Doppler in grading middle cerebral artery stenosis 
in comparison with magnetic resonance angiography. J Neuroimaging 2002;12:213-218.]  At our 
laboratory, we perform >1200 transcranial Doppler examinations each year.   
Foot examination was performed with particular attention to the presence or absence of 
deformity (claws toes, callus, hammer toes), skin changes (atrophic changes such as dry skin and 
loss of hair, healed ulcers) and distal sensory neuropathy. The latter was considered to be present if 
the patient had typical symptoms of numbness or abnormal sensation in the distal limbs 
accompanied by at least 1 physical sign or 2 abnormal signs in the absence of symptoms. The 
physical signs included diminished ankle reflexes or sensation using monofilament (diminished 
sensation over foot dorsum or sole with normal skin) or graduated tuning fork where normality was 
defined as ≥6/8 or ≥4/8 in those <65 or ≥65 years subjects, respectively. The patient was considered 
to be at risk of developing diabetic foot syndrome if 2 of 3 of these risk factors (symmetrical 
sensory neuropathy, deformities or skin changes) were present. Foot pulses were examined in each 
patient and the ankle-brachial systolic arterial pressure ratio (ABR) was determined by Doppler 
examination in those with abnormal pulses.  An ABR <0.9 in either leg was considered suggestive 
and <0.7 confirmatory of PVD.18  Retinopathy was assessed by an ophthalmologist in all the 
patients.  The fundi were examined through dilated pupils and retinopathy was considered to be 
present if there was one or more areas of haemorrhages, microaneurysms, cotton wool spots and/or 
laser coagulation scars related to diabetic retinopathy.  Symptomatic peripheral vascular disease 
was diagnosed if claudication, gangrene or ischaemia-related amputation were present. Histories of 
coronary and cerebrovascular disease were recorded, as were the use of alcohol and tobacco 
products. 
Data from normally distributed parameters are presented as mean±SD, whereas skewed data 
were logarithmically transformed and expressed as geometric mean with 95% confidence intervals. 
Differences in anthropometric and fasting plasma biochemical parameters between those patients 
with increasing levels of albuminuria were examined using analysis of variance.  Dichotomous 
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variables were compared using the χ2-test.  Gender was coded 0 and 1 for male and female, 
respectively.   
For the regression analyses, all 966 diabetic patients were included.  Stepwise multiple 
linear regression analysis was used to determine independent predictors of albuminuria (24 hour 
urinary albumin excretion rate).  These variables included age, gender, body mass index, waist 
circumference, systolic blood pressure, pulse pressure, diagnosis of hypertension, glucose, 
triglycerides, HDL- and LDL-cholesterol levels and duration of diabetes.  
MCA stenosis, and retinopathy were chosen as examples of macro- and microvascular 
disease, and were included in the forward conditional linear regression analyses to determine 
independent predictors of these conditions. These variables included were as described above for 
the stepwise multiple regression analysis. The variables included in the analyses were linearly 
related to the dependent variable. The Statistical Package for the Social Sciences was used in the 
analyses (SPSS. version 11.0.1, 2001, SPSS Inc, Chicago, Illinois, USA). 
 
Results 
The albuminuric status of the 966 patients with Type 2 diabetes was determined from a 24 hour 
urine collection, from whom 857 patients matched for age, gender, duration and age of onset of 
diabetes were identified and included 475 patients with normo-, 250 with micro-, and 132 with 
macroalbuminuria.  In the matched groups, worsening albuminuria was associated with 
significantly increasing general (BMI) and central (waist circumference) adiposity (Table 1).  
Although increasing proportions of patients with micro- and macroalbuminuria received blood 
pressure and lipid-lowering therapies (Table 2), blood pressure and lipid (total, LDL-cholesterol 
and triglyceride) parameters increased significantly, whilst HDL-cholesterol levels were lower 
(Table 1).  The changes in LDL-cholesterol levels were particularly evident in the group with 
macroalbuminuria.  The proportion of current smokers was found to increase with albuminuria, 
with most of the current smokers being male (89.6%). 
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The prevalence of MCA stenoses, measured using transcranial Doppler, doubled between 
those with normoalbuminuria compared to those with macroalbuminuria (Table 2), whereas the 
proportion of those having stenoses in both arteries was nearly three times higher.  Almost one 
quarter of the patients with macroalbuminuria had evidence of stenoses in the MCA.  Concomitant 
increases in a number of other macrovascular conditions were also noted, with significant increases 
in the prevalence of patients with a history of myocardial infarction, and markers of peripheral 
vascular disease, including diabetic foot complications and impotency.  Similarly, the 
microvascular complication, retinopathy, was also significantly higher in those with 
macroalbuminuria, being found in 50% of the subjects, which was 3.5 times more frequent than in 
the diabetic patients with normoalbuminuria. 
A large number of the cardiovascular risk factors were independent predictors of 24 hour 
urinary albumin excretion rate.  These included systolic blood pressure (β=0.21, p<0.001), duration 
of diabetes (β=0.19, p<0.001), triglycerides (β=0.10, p=0.008), male gender (β=-0.09, p=0.008), 
LDL-cholesterol (β=0.11, p<0.001), diagnosis of hypertension (β=0.13, p=0.001), body mass index 
(β=0.09, p=0.002), and smoking (β=0.07, p=0.033) and these accounted for 21% of the variance.  
The regression equation is as follows: 24 hour urinary albumin excretion rate = [0.007⋅systolic 
blood pressure] + [0.24⋅duration of diabetes] + [0.32⋅triglycerides] – [0.13⋅male gender] + 
[0.08⋅LDL-cholesterol] + [0.20⋅diagnosis of hypertension] + [0.02⋅body mass index] + 
[0.07⋅smoking] – 0.62; R2=0.21, F=34.8, p<0.001. 
The forward conditional linear regression analyses identified urinary albumin excretion rate 
as an independent predictor of both vascular conditions.  The regression equations were as follows: 
MCA stenosis = [0.03⋅age] + [0.49⋅albumin excretion rate] – 3.90, Nagelkerke R2=0.07, χ2=32.5, 
p<0.001; and retinopathy = [-0.49⋅male gender] + [1.04⋅albumin excretion rate] + [1.63⋅duration of 
diabetes] + [1.91⋅glucose] + [0.02⋅pulse pressure] – 6.16, Nagelkerke R2=0.41, χ2=276.7, p<0.001. 
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Discussion 
There is a clear relationship between ageing, gender and the duration and onset of diabetes and the 
development of cardiovascular and renal vascular complications.9-13  We therefore matched the 
groups of diabetic patients with normo-, micro- and macroalbuminuria for these parameters to limit 
any potential confounding effect.  However, despite this, increasing levels of albuminuria were 
closely associated with increases in a number of cardiovascular risk factors, including adiposity, 
blood pressure and lipid levels, with these parameters being independent predictors of 24 hour 
albumin excretion rate.  This supports that the adverse metabolic milieu in patients with diabetes 
increases the risk of developing nephropathy and cardiovascular disease.10  Albuminuria has been 
reported to be a marker of atherosclerotic disease, rather than directly promoting vascular disease.  
The presence of these concomitant risk factors is likely to promote endothelial dysfunction 
throughout the vasculature,19 including in the glomeruli.  High blood pressure, glucose and lipid 
levels have all been associated with alterations in the permeability of glomerular capillaries to 
protein that results in proteinuria.20,21 
 Smoking has been reported to be a major risk factor for atherogenesis and vascular disease 
mortality.22,23 Reflecting the smoking habits in Hong Kong generally, 90% of the smokers were 
males, and a third of males with macroalbuminuria currently smoked whereas only 3% of females 
in that group smoked.  In the current study, smoking was an independent predictor and the 
prevalence increased with increasing albuminuria supporting an involvement in damaging the 
vasculature.  Tobacco smoke, which contains more than 4000 chemicals,24 can damage the vascular 
endothelium directly.25 Furthermore, smoking can increase oxidative stress and levels of acute 
phase proteins.25,26  Even in the absence of smoking, other studies have reported that these 
parameters are increased suggesting an inflammatory component to the development of 
albuminuria.27 
 Type 2 diabetes is closely associated with micro and macrovascular disease, the major 
causes of morbidity and mortality in these patients.28 In our study, the association of albuminuria 
and cardiovascular events as well as other vascular disease entities 29,30 were also observed. A key 
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measure of cerebrovascular disease in our study was the transcranial Doppler measurement of 
intracranial stenoses.  Intracerebral haemorrhage has been reported to be 2-3 times more frequent in 
Chinese than in Caucasian populations, accounting for 20-30% of strokes.5  In Hong Kong, of 705 
consecutively recruited stroke patients, occlusive arteries were found in 345 patients (49%), 37% of 
the total had only intracranial stenosis, 10% tandem (intracranial and extracranial) lesions and 2.3% 
only extracranial lesions.17 Stenosis of the MCA was the most common lesion, found in 35.9% of 
the patients.17 In the current study, we found a clear relationship between increasing levels of 
albuminuria and MCA stenoses, although age and albuminuria collectively only accounted for 7% 
of variance.  This suggests additional unmeasured parameters further contribute to the development 
of intracranial atherosclerotic disease.  Given the chronic nature of the development of stenotic 
arteries, it may be that different parameters contribute at different stages in the pathogenesis, which 
a cross-sectional study such as this would not be able to determine. 
 The conventional cardiovascular risk factors, including albuminuria, explained a greater 
proportion of the variance (41%) of the microvascular diabetic complication, retinopathy.  Diabetic 
eye disease is the leading cause of new cases of blindness in many developed countries, for which 
macular oedema and proliferative retinopathy are major causes of loss of vision.31  In the UK 
Prospective Diabetes Study, tight control of blood pressure and glycaemia effectively reduced the 
development of retinopathy.32,33  These parameters were also independent predictors of retinopathy 
in the current study. 
 Given the close association between multiple vascular risk factors and albuminuria, it 
should be considered useful as an early indicator of both micro- and macrovascular atherosclerotic 
disease. Microalbuminuria is also a marker for the development of renal failure,13 we have 
previously reported that an albumin-to-creatinine ratio >5.6 mg/mmol was a predictor of end-stage 
renal disease in Chinese type 2 diabetic patients.11  It is therefore necessary to develop the most 
effective strategy to optimise all these risk factors, including albuminuria, to reduce the associated 
devastating cardiovascular complications. However, it is important to recognise the therapeutic 
challenges in the management of Type 2 diabetes.  Despite intensive therapy,34 treatment goals as 
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defined by most international guidelines were only attained in 60-80% of type 2 diabetic patients.  
In another study, optimal glycaemic control (HbA1c 6-7%) was only achieved in 10-30% of 
patients.34 
 In summary, albuminuria was closely related to increasing levels of cardiovascular risk 
factors and micro- and macrovascular disease in this group of Type 2 diabetic patients and should 
be considered as a marker of early vascular disease.  
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Table 1 Demographic features in the 857 age, gender, duration and onset of diabetes-matched Chinese Type 2 diabetic patients categorised by 
albuminuric status 
 
Parameters (%) Albuminuria*     
 Normo- Micro- Macro- p value 
Numbers 475 250 132 - 
Age (years) 53.5±10.4 53.0±11.4 55.3±11.3 NS 
Gender (% Male) 43.4 44.4 53.8 NS 
Duration of diabetes (years) 2.5 (2.2-2.8) 2.7 (2.3-3.2) 3.3 (2.6-4.1) NS 
Age of diabetes onset (years) 49.5±10.6 48.3±11.5 50.0±11.0 NS 
24h albumin-to-creatinine ratio (ACR, mg/mmol) 1.0 (1.0-1.1) 6.0 (5.5-6.6) 85.5 (70.9-103.1) <0.001 
24h albumin excretion rate (AER, µg/min) 5.9 (5.7-6.2) 36.6 (33.9-39.5) 530 (445-631) <0.001 
Albumin-to-creatinine ratio >5.6 mg/mmol (%) 4.1 56.7 97.7 <0.001 
Plasma creatinine (µmol/L) 72.1±18.7 73.6±23.3 112.4±88.8 <0.001 
Body mass index (kg/m2) 24.1±3.4 25.4±3.8 25.7±3.7 <0.001 
Waist circumference (cm) 82.7±9.0 86.5±9.4 87.2±9.4 <0.001 
Systolic blood pressure (mm Hg) 133±20 139±21 149±24 <0.001 
Diastolic blood pressure (mm Hg) 80±11 83±10 85±13 <0.001 
Mean arterial pressure (mm Hg) 98±13 102±12 107±15 <0.001 
Pulse pressure (mm Hg) 53±15 56±17 64±19 <0.001 
Glucose (mmol/L) 8.7 (8.4-9.0) 9.3 (9.0-9.7) 8.9 (8.7-9.5) 0.047 
Glycosylated haemoglobin A1c(%) 7.8±2.0 8.2±2.0 8.1±2.0 NS 
Total cholesterol (mmol/L) 5.6±1.2 5.6±1.2 6.1±1.4 <0.001 
HDL-cholesterol (mmol/L) 1.30±0.38 1.22±0.34 1.15±0.35 <0.001 
LDL-cholesterol (mmol/L) 3.55±0.93 3.52±0.93 3.91±1.23 0.001 
Triglyceride (mmol/L) 1.35 (1.28-1.43) 1.60 (1.48-1.73) 1.94 (1.72-2.18) <0.001 
Mean±SD or geometric mean (95% confidence intervals); NS = non-significant, Rx=receiving therapy, * Normoalbuminuria was classified as an AER 
<20 µg/min, microalbuminuria as an AER ≥20 to <200 µg/min and macroalbuminuria as an AER ≥200 µg/min.13 
Concomitant disorders (%) Albuminuria*   
 Normo- Micro- Macro- p value 
Numbers 475 250 132 - 
MCA stenosis 1/2 vessel/combined  6.3 / 4.8 / 11.1 7.2 / 8.8 / 16.0 9.8 / 13.6 / 23.4 <0.001 
Foot affected  2.7 4.4 9.1 0.002 
Impotence (% of males) 19.4 20.5 32.4 0.044 
Peripheral vascular disease  2.8 4.4 7.6 0.012 
History of myocardial infarction  2.5 5.6 6.9 0.010 
Retinopathy  14.4 30.4 50.8 <0.001 
Prevalence of hypertension (Rx)  44.2 (21.7) 57.6 (31.2) 77.3 (51.2) <0.001 (<0.001) 
Prevalence of dyslipidaemia (Rx)  46.5 (4.0) 48.6 (4.3) 69.7 (9.9) <0.001(0.025) 
Treatment of diabetes 75.5 81.3 84.1 0.018 
     
Smoking consumption (ex/current) 12.4 / 13.0 13.2 / 18.0 20.8 / 19.2 0.002 
Alcohol consumption (ex/current) 9.5 / 7.8 14.0 / 7.6 19.4 / 7.8 NS 
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Table 2 Prevalence rates of concomitant disorders and smoking and alcohol consumption in the 857 age, gender, duration and onset of diabetes-
matched Chinese Type 2 diabetic patients categorised by albuminuric status 
Mean±SD or geometric mean (95% confidence intervals); NS = non-significant, Rx=receiving therapy, *Normoalbuminuria was classified as an AER <20 
µg/min, microalbuminuria as an AER ≥20 to <200 µg/min and macroalbuminuria as an AER ≥200 µg/min.13   
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Figure Increasing 24 hour urinary albumin excretion rate in 857 age, gender, duration and 
onset of diabetes-matched Chinese Type 2 diabetic patients with middle cerebral artery 
stenoses in 0, 1 or 2 vessels (ANOVA p value<0.001) 
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